Results 51 to 60 of about 10,417,976 (225)

French recommendations for the management of non-infectious chronic uveitis.

, 2023
This French National Diagnostic and Care Protocol (NDPC) includes both pediatric and adult patients with non-infectious chronic uveitis (NICU) or non-infectious recurrent uveitis (NIRU).
Errera, M.H., Seve, P., Kaplanski, G., Audouin-Pajot, C., Monnet, D., Kodjikian, L., Saadoun, D., Bodaghi, B., Belot, A., Kone-Paut, I., Uettwiller, F., Weber, M., Quartier, P., Miceli-Richard, C.   +13 more
core   +1 more source

Incidence, Risk Factors and Management of Adverse Events in Contemporary Real‐World Care of Children with Juvenile Idiopathic Arthritis

Arthritis Care &Research, Accepted Article.
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAE and SAE) in children with newly diagnosed Juvenile Idiopathic Arthritis (JIA) in Canada. Methods We enrolled patients within 3 months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry,
Bashayer Alnuaimi, Roberta A. Berard, Jean‐Philippe Proulx‐Gauthier, Heinrike Schmeling, Michelle Batthish, Gilles Boire, Adam M. Huber, Dax G. Rumsey, Jaime Guzman, Gaëlle Chédeville, The CAPRI registry Investigators   +10 more
wiley   +1 more source

Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice

Background: Non-infectious uveitis is a diverse group of inflammatory conditions that collectively account for substantial blindness worldwide. Expert guidelines and results of clinical trials guide treatment, but real-world clinical care is impacted by ...
McCluskey, Peter J, Fabiani, Claudia, Ferreira, Lisia Barros, Thorne, Jennifer E, International Study Group for Systemic Immunomodulatory Drug Treatment of Non‐Infectious Uveitis, Matthews, Janet M, Smith, Justine R, Branford, Jasmin A, Bodaghi, Bahram   +8 more
core   +2 more sources

Secukinumab in refractory non-infectious anterior uveitis

Frontiers in Ophthalmology
BackgroundSecukinumab is a monoclonal antibody that selectively neutralizes interleukin-17A and has shown efficacy in the treatment of psoriatic arthritis, psoriasis, and axial spondyloarthritis.
Otto M. Olivas-Vergara, Inés Hernanz, Pablo E. Borges-Deniz, Fredeswinda Romero-Bueno, Olga Sanchez-Pernaute, Ester Carreño   +5 more
doaj   +1 more source

mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol

Systematic Reviews, 2018
Background Non-infectious uveitis represents a sub-type of intraocular inflammation often associated with disorders of immune dysregulation. If untreated, the intraocular inflammation may progress to severe visual impairment and blindness.
Joshua Blair, Robert Barry, Philip I. Murray, David J. Moore, Alastair K. Denniston   +4 more
doaj   +1 more source

Current approaches to treatment of uveitis in immune-mediated inflammatory rheumatic disease

Научно-практическая ревматология, 2020
Non-infectious uveitis is the leading and insufficiently studied cause of irreversible decline in visual functions in patients with immune-mediated inflammatory rheumatic disease (IMIRDs).
T. A. Lisitsyna, Z. S. Alekberova, G. A. Davydova, T. M. Reshetnyak, L. A. Katargina, E. L. Nasonov   +5 more
doaj   +1 more source

Optimising drug therapy for non-infectious uveitis

, 2018
Introduction Uveitis encompasses a wide variety of sight-threatening diseases characterized by intraocular inflammation. It is often classified as infectious and non-infectious uveitis.
Zafar, Sidra, Shahab, Mohammad Ali, Mir, Tahreem Aman   +2 more
core   +1 more source

GHRHR Deficiency Enhances Retinal Ganglion Cell Survival and Visual Functions in Experimental Glaucoma by Inhibiting Ferroptosis

Advanced Science, EarlyView.
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong, Ming Ho Yam, Jiaxin Zhang, Lin Du, Linbin Zhou, Yolanda Wong Ying Yip, Bo Man Ho, Hemlata Bisnauthsing, Jiahui Li, Ivan Kong, Shushu Xu, Changzhen Fu, Karl K.H. So, Joaquim S.L. Vong, Ling‐Ping Cen, Ming‐Ming Yang, Khazeema Yousaf, Mai Har Sham, Sun On Chan, Poemen P. Chan, Chi Pui Pang, Clement C. Tham, Jing Na He, Jian Li, Wai Kit Chu   +24 more
wiley   +1 more source

Intraocular Implants for the Treatment of Autoimmune Uveitis

Journal of Functional Biomaterials, 2015
Uveitis is the third leading cause of blindness in developed countries. Currently, the most widely used treatment of non-infectious uveitis is corticosteroids.
Darren J. Lee
doaj   +1 more source

Clinical Variations of Uveitis in Immuno-Inflammatory Diseases. Review of the Literature. Part 2

Oftalʹmologiâ, 2023
In the previous part of the review clinical and diagnostic aspects of some non-infectious uveitis in patients with immunoinflammatory diseases were discussed.
G. A. Davydova, T. A. Lisitsyna, L. A. Kovaleva, E. S. Sorozhkina, A. A. Zaitseva, A. A. Baisangurova   +5 more
doaj   +1 more source